BACKGROUND: Cardiovascular disease continues to be the single most common cause of death and to account for the largest single portion of treatment costs in Germany. Reliable data on regional differences in the frequency of cardio - vascular disease are important for the planning of targeted care structures and preventive measures. METHODS: Pooled data from the German Health Update (GEDA), a nationwide telephone health survey conducted in 2009, 2010 and 2012 (n = 62 214) were used to estimate the lifetime prevalence of major cardiovascular disease (self-reported medical diagnosis of myocardial infarction, other coronary heart disease, stroke, or congestive heart failure) in each of the German federal states. The influence of sociodemographic factors on regional prevalence differences was examined in adjusted logistic regression analyses. Prevalences were compared with mortality rates from cardiovascular disease that were obtained from cause-of-death statistics. RESULTS: The lifetime prevalence of cardiovascular disease in Germany ranged from 10.0% in Baden-W¨rttemberg to 15.8% in Saxony-Anhalt. After adjustment for age, sex, socioeconomic status, and size of the communities of residence, nine of the other 15 states had significantly higher prevalences than Baden-W¨rttemberg, with odds ratios ranging from 1.26 (Hesse) to 1.55 (Saxony-Anhalt). Four of the five states that previously constituted the German Democratic Republic (East Germany) had above-average figures for prevalence and mortality. CONCLUSION: There are relevant differences among the German federal states in the lifetime prevalence of major cardiovascular disease, which are only partly accounted for by differences in age and sex distribution, socioeconomic status, and community size.
BACKGROUND:Cardiovascular disease continues to be the single most common cause of death and to account for the largest single portion of treatment costs in Germany. Reliable data on regional differences in the frequency of cardio - vascular disease are important for the planning of targeted care structures and preventive measures. METHODS: Pooled data from the German Health Update (GEDA), a nationwide telephone health survey conducted in 2009, 2010 and 2012 (n = 62 214) were used to estimate the lifetime prevalence of major cardiovascular disease (self-reported medical diagnosis of myocardial infarction, other coronary heart disease, stroke, or congestive heart failure) in each of the German federal states. The influence of sociodemographic factors on regional prevalence differences was examined in adjusted logistic regression analyses. Prevalences were compared with mortality rates from cardiovascular disease that were obtained from cause-of-death statistics. RESULTS: The lifetime prevalence of cardiovascular disease in Germany ranged from 10.0% in Baden-W¨rttemberg to 15.8% in Saxony-Anhalt. After adjustment for age, sex, socioeconomic status, and size of the communities of residence, nine of the other 15 states had significantly higher prevalences than Baden-W¨rttemberg, with odds ratios ranging from 1.26 (Hesse) to 1.55 (Saxony-Anhalt). Four of the five states that previously constituted the German Democratic Republic (East Germany) had above-average figures for prevalence and mortality. CONCLUSION: There are relevant differences among the German federal states in the lifetime prevalence of major cardiovascular disease, which are only partly accounted for by differences in age and sex distribution, socioeconomic status, and community size.
Authors: Yuji Okura; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer Journal: J Clin Epidemiol Date: 2004-10 Impact factor: 6.437
Authors: Cornelia Lange; Franziska Jentsch; Jennifer Allen; Jens Hoebel; Anna Lena Kratz; Elena von der Lippe; Stephan Müters; Patrick Schmich; Jürgen Thelen; Matthias Wetzstein; Judith Fuchs; Thomas Ziese Journal: Int J Epidemiol Date: 2015-05-15 Impact factor: 7.196
Authors: T Lampert; L E Kroll; S Müters; H Stolzenberg Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2013-01 Impact factor: 1.513
Authors: Gary F Mitchell; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Michael J Pencina; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin Journal: Circulation Date: 2010-01-18 Impact factor: 29.690
Authors: Susanne Moebus; Jens Hanisch; Peter Bramlage; Christian Lösch; Hans Hauner; Jürgen Wasem; Karl-Heinz Jöckel Journal: Dtsch Arztebl Int Date: 2008-03-21 Impact factor: 5.594
Authors: Michael J Pencina; Ralph B D'Agostino; Martin G Larson; Joseph M Massaro; Ramachandran S Vasan Journal: Circulation Date: 2009-06-08 Impact factor: 29.690
Authors: Nick Townsend; Denis Kazakiewicz; F Lucy Wright; Adam Timmis; Radu Huculeci; Aleksandra Torbica; Chris P Gale; Stephan Achenbach; Franz Weidinger; Panos Vardas Journal: Nat Rev Cardiol Date: 2021-09-08 Impact factor: 32.419
Authors: Claudia Diederichs; Hannelore Neuhauser; Viktoria Rücker; Markus A Busch; Ulrich Keil; Anthony P Fitzgerald; Peter U Heuschmann Journal: PLoS One Date: 2018-01-02 Impact factor: 3.240
Authors: Jesper Weile; Christian A Frederiksen; Christian B Laursen; Ole Graumann; Erik Sloth; Hans Kirkegaard Journal: Scand J Trauma Resusc Emerg Med Date: 2020-05-29 Impact factor: 2.953
Authors: Lina Jaeschke; Astrid Steinbrecher; Karin Halina Greiser; Marcus Dörr; Thomas Buck; Jakob Linseisen; Christa Meisinger; Wolfgang Ahrens; Heiko Becher; Klaus Berger; Bettina Braun; Hermann Brenner; Stefanie Castell; Beate Fischer; Claus-Werner Franzke; Sylvia Gastell; Kathrin Günther; Wolfgang Hoffmann; Bernd Holleczek; Annika Jagodzinski; Rudolf Kaaks; Alexander Kluttig; Gérard Krause; Lilian Krist; Oliver Kuß; Anna-Therese Lehnich; Michael Leitzmann; Wolfgang Lieb; Markus Löffler; Karin B Michels; Rafael Mikolajczyk; Annette Peters; Tamara Schikowski; Sabine Schipf; Börge Schmidt; Matthias Schulze; Henry Völzke; Stefan N Willich; Tobias Pischon Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2020-04 Impact factor: 1.513
Authors: Friedrich Trefz; Ania C Muntau; Kim M Schneider; Julia Altevers; Christian Jacob; Sebastian Braun; Wolfgang Greiner; Ashok Jha; Mohit Jain; Ignacio Alvarez; Paul Lane; Claudia Zeiss; Frank Rutsch Journal: Mol Genet Metab Rep Date: 2021-05-13